Technology companies Apple and Google have teamed up to build an element of contact tracing to aid in the COVID-19 response.

While emerging conventional wisdom may state biopharmaceutical companies could see a boon as a result of the COVID-19 pandemic thanks to new treatment and vaccine opportunities, the sector may not come out on top.

Biopharmaceutical company AstraZeneca has received more than $1 billion in funding from BARDA for the development, production and delivery of Oxford University's vaccine for COVID-19.

ACR outlined its concerns with the American Board of Radiology, and the nonprofit’s controversial “maintenance of certification” program, in a recently passed resolution. 

Rosiglitazone was once a popular treatment for Type 2 diabetes, but it fell out of favor due to a variety of side effects.

Investigators from Northwell Health hope such data could prove pivotal in making a case for further relief from federal and state governments. 

In older adults at higher risk for Alzheimer's disease, one year of aerobic exercise enhanced flow in the anterior cingulate cortex and the hippocampus, according to a new study.

Understood as a virtual army in the war against COVID-19, AI has vast stockpiles of potential weaponry with which to wage many a battle. That’s the good news.

The World Health Organization estimates that 82 million people will be affected by dementia by the year 2030—could maintaining a healthy heart be one way to keep such conditions at bay?

A former consultant to the 11-practice provider first filed suit in 2013, with the DOJ recently announcing its “partial” intervention.